| c-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-Jun X Xie, TS Kaoud, R Edupuganti, T Zhang, T Kogawa, Y Zhao, ... Oncogene 36 (18), 2599-2608, 2017 | 89 | 2017 |
| Trafficking of circulating pro-NK cells to the decidualizing uterus: regulatory mechanisms in the mouse and human MJ Van Den Heuvel, S Chantakru, X Xie, SS Evans, F Tekpetey, PA Mote, ... Immunological investigations 34 (3), 273-293, 2005 | 85 | 2005 |
| MEK inhibitor selumetinib (AZD6244; ARRY-142886) prevents lung metastasis in a triple-negative breast cancer xenograft model C Bartholomeusz, X Xie, MK Pitner, K Kondo, A Dadbin, J Lee, H Saso, ... Molecular cancer therapeutics 14 (12), 2773-2781, 2015 | 81 | 2015 |
| A review of trafficking and activation of uterine natural killer cells MJ Van Den Heuvel, X Xie, C Tayade, C Peralta, Y Fang, S Leonard, ... American journal of reproductive immunology 54 (6), 322-331, 2005 | 76 | 2005 |
| JNK signaling in stem cell self-renewal and differentiation T Semba, R Sammons, X Wang, X Xie, KN Dalby, NT Ueno International journal of molecular sciences 21 (7), 2613, 2020 | 65 | 2020 |
| Pathways participating in activation of mouse uterine natural killer cells during pregnancy X Xie, H He, M Colonna, T Seya, T Takai, BA Croy Biology of reproduction 73 (3), 510-518, 2005 | 52 | 2005 |
| Differential functions of ERK1 and ERK2 in lung metastasis processes in triple-negative breast cancer M Gagliardi, MK Pitner, J Park, X Xie, H Saso, RA Larson, RM Sammons, ... Scientific reports 10 (1), 8537, 2020 | 37 | 2020 |
| Discovery of a potent inhibitor of MELK that inhibits expression of the anti-apoptotic protein Mcl-1 and TNBC cell growth R Edupuganti, JM Taliaferro, Q Wang, X Xie, EJ Cho, F Vidhu, P Ren, ... Bioorganic & medicinal chemistry 25 (9), 2609-2616, 2017 | 35 | 2017 |
| Bisphosphorylated PEA-15 sensitizes ovarian cancer cells to paclitaxel by impairing the microtubule-destabilizing effect of SCLIP X Xie, C Bartholomeusz, AA Ahmed, A Kazansky, L Diao, KA Baggerly, ... Molecular cancer therapeutics 12 (6), 1099-1111, 2013 | 27 | 2013 |
| Antibody-dependent cell-mediated cytotoxicity-and complement-dependent cytotoxicity-independent bactericidal activity of an IgG against Pseudomonas aeruginosa O6ad X Xie, MD McLean, JC Hall The Journal of Immunology 184 (7), 3725-3733, 2010 | 25 | 2010 |
| Analysis of the Contributions of l‐Selectin and CXCR3 in Mediating Leukocyte Homing to Pregnant Mouse Uterus X Xie, Z Kang, LN Anderson, H He, B Lu, B Anne Croy American Journal of Reproductive Immunology 53 (1), 1-12, 2005 | 25 | 2005 |
| Serotonin analogues as inhibitors of breast cancer cell growth J Jose, CDJ Tavares, ND Ebelt, A Lodi, R Edupuganti, X Xie, AK Devkota, ... ACS Medicinal Chemistry Letters 8 (10), 1072-1076, 2017 | 24 | 2017 |
| In vivo models for studying homing and function of murine uterine natural killer cells BA Croy, X Xie Placenta and Trophoblast: Methods and Protocols Volume 2, 77-92, 2006 | 20 | 2006 |
| Identification of the JNK-active triple-negative breast cancer cluster associated with an immunosuppressive tumor microenvironment T Semba, X Wang, X Xie, EN Cohen, JM Reuben, KN Dalby, JP Long, ... JNCI: Journal of the National Cancer Institute 114 (1), 97-108, 2022 | 17 | 2022 |
| Birinapant Enhances Gemcitabine's Antitumor Efficacy in Triple-Negative Breast Cancer by Inducing Intrinsic Pathway–Dependent Apoptosis X Xie, J Lee, H Liu, T Pearson, AY Lu, D Tripathy, GR Devi, ... Molecular cancer therapeutics 20 (2), 296-306, 2021 | 17 | 2021 |
| Antitumor activity of KW-2450 against triple-negative breast cancer by inhibiting Aurora A and B kinases K Kai, K Kondo, X Wang, X Xie, MK Pitner, ME Reyes, AM Torres-Adorno, ... Molecular cancer therapeutics 14 (12), 2687-2699, 2015 | 17 | 2015 |
| Methods of improving the therapeutic efficacy and utility of antibody fragments CJ Hall, MD McLean, X Xie, N Weisser, KC Almquist US Patent App. 13/127,926, 2012 | 10 | 2012 |
| Complexes with anti-epitope tag IgGs improve the therapeutic potential of epitope-tagged antibody fragments X Xie, NE Weisser, MD McLean, JC Hall Molecular immunology 47 (7-8), 1529-1534, 2010 | 9 | 2010 |
| Antibody Fragment Engineering and Applications in Diagnosis and X Xie, G Richard, JC Hall Antibodies Applications and New Developments, 225, 2012 | 5 | 2012 |
| Emerging drug targets for triple-negative breast cancer: a guided tour of the preclinical landscape X Xie, J Lee, T Iwase, M Kai, NT Ueno Expert Opinion on Therapeutic Targets 26 (5), 405-425, 2022 | 4 | 2022 |
